Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trastuzumab Continuation Beyond Progression in HER2+ Metastatic Breast Cancer
NCT00444587Phase 2Completed
- Sponsor
- Roche
- Start
- Mar 2007
- Primary completion
- Aug 2011
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 8
01
Overview
A Phase 2 trial of trastuzumab in breast cancer, sponsored by Roche. Started Mar 2007; status: completed.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00444587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00444587.